TITAN-Studie - Evaluation von Apalutamid bei Patienten mit metastasiertem hormonsensitivem Prostatakarzinom

Translated title of the contribution: TITAN study: Evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)

Axel S. Merseburger*, Henrik Suttmann

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'TITAN study: Evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science